Cargando…

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway

Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk for progression to cirrhosis and hepatocellular carcinoma (HCC). Mitochondrial dysfunction appears to play a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Hisashi, Takaki, Akinobu, Tsuzaki, Ryuichiro, Yasunaka, Tetsuya, Koike, Kazuko, Shimomura, Yasuyuki, Seki, Hiroyuki, Matsushita, Hiroshi, Miyake, Yasuhiro, Ikeda, Fusao, Shiraha, Hidenori, Nouso, Kazuhiro, Yamamoto, Kazuhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077577/ https://www.ncbi.nlm.nih.gov/pubmed/24983359 http://dx.doi.org/10.1371/journal.pone.0100627

Ejemplares similares

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma
por: Shimomura, Yasuyuki, et al.
Publicado: (2017)

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
por: Takaki, Akinobu, et al.
Publicado: (2013)

Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
por: Koike, Kazuko, et al.
Publicado: (2015)

Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis
por: Miyahara, Koji, et al.
Publicado: (2013)

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C
por: Moritou, Yuki, et al.
Publicado: (2013)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis
por: Katayama, Akihiro, et al.
Publicado: (2015)

Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
por: Tatsukawa, Masashi, et al.
Publicado: (2011)

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis
por: Nakatsuka, Atsuko, et al.
Publicado: (2016)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

Serial Changes of Serum Growth Factor Levels and Liver Regeneration after Partial Hepatectomy in Healthy Humans
por: Matsumoto, Kazuyuki, et al.
Publicado: (2013)

Twist expression promotes migration and invasion in hepatocellular carcinoma
por: Matsuo, Noriyuki, et al.
Publicado: (2009)

A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes
por: Iwamuro, Masaya, et al.
Publicado: (2012)

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation
por: Saragai, Yosuke, et al.
Publicado: (2018)

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2013)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: KATAOKA, JUNRO, et al.
Publicado: (2016)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: Kataoka, Junro, et al.
Publicado: (2017)

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence
por: Takaki, Akinobu, et al.
Publicado: (2015)

Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis
por: Nakanishi, Yutaka, et al.
Publicado: (2011)

Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
por: Hanafusa, Tadashi, et al.
Publicado: (2005)

The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity
por: Zakharova, Natalia, et al.
Publicado: (2023)

Human hepatocyte carcinogenesis
por: SHIRAHA, HIDENORI, et al.
Publicado: (2013)

Metabolic flexibility and carnitine flux: The role of carnitine acyltransferase in glucose homeostasis
por: Miyata, Yugo, et al.
Publicado: (2013)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
por: Takeuchi, Yasuto, et al.
Publicado: (2023)

Study Protocol for a Trial: A Single-Arm, Open-Labeled Study Evaluating Transcatheter Arterial Embolization Plus Everolimus Combination Therapy for Patients With Liver Metastasis of Gastroenteropancreatic Neuroendocrine Tumors
por: Takeuchi, Yasuto, et al.
Publicado: (2022)

Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
por: Oyama, Atsushi, et al.
Publicado: (2023)

Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4(+) T cells through AMPK activation
por: Takahara, Masahiro, et al.
Publicado: (2019)

Circulating tumor DNA dynamics analysis in a xenograft mouse model with esophageal squamous cell carcinoma
por: Terasawa, Hiroyuki, et al.
Publicado: (2021)

A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency
por: Ikeda, Naohiro, et al.
Publicado: (2017)

Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis
por: Kuramoto, Junko, et al.
Publicado: (2022)

Hepatic and Gastric Involvement in a Case of Systemic Sarcoidosis Presenting with Rupture of Esophageal Varices
por: Saito, Hiroaki, et al.
Publicado: (2017)

Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C
por: Takaki, Akinobu, et al.
Publicado: (2014)

Safe and cost-effective control of post-transplantation recurrence of hepatitis B
por: Takaki, Akinobu, et al.
Publicado: (2015)

Alcohol and hepatocellular carcinoma
por: Matsushita, Hiroshi, et al.
Publicado: (2019)

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
por: Miyahara, K, et al.
Publicado: (2013)

Gastric polyps' regression after potassium‐competitive acid blocker cessation
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Trimethylamine generation in patients receiving hemodialysis treated with l-carnitine
por: Ozasa, Hisashi, et al.
Publicado: (2014)

Carnitine and Depression
por: Liu, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_toq7ge63qiloer4qfvdi466g7u